These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21857298)

  • 1. Why did the scale-up of HIV treatment work? A case example from Malawi.
    Harries AD; Makombe SD; Libamba E; Schouten EJ
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S64-7. PubMed ID: 21857298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No need for apologies.
    El-Sadr WM; Gonsalves G; Mugyenyi P
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S68-71. PubMed ID: 21857299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Game changers: why did the scale-up of HIV treatment work despite weak health systems?
    De Cock KM; El-Sadr WM; Ghebreyesus TA
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S61-3. PubMed ID: 21857297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical interactions between the Global Fund-supported HIV programs and the health system in Ghana.
    Atun R; Pothapregada SK; Kwansah J; Degbotse D; Lazarus JV
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S72-6. PubMed ID: 21857300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malawi's contribution to "3 by 5": achievements and challenges.
    Libamba E; Makombe SD; Harries AD; Schouten EJ; Yu JK; Pasulani O; Mhango E; Aberle-Grasse J; Hochgesang M; Limbambala E; Lungu D
    Bull World Health Organ; 2007 Feb; 85(2):156-60. PubMed ID: 17308738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging HIV programs to deliver an integrated package of health services: some words of caution.
    Grépin KA
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S77-9. PubMed ID: 21857301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bridging the divide.
    El-Sadr WM; Rabkin M; Atun R; De Cock KM
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S59-60. PubMed ID: 21857296
    [No Abstract]   [Full Text] [Related]  

  • 8. Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport.
    Zachariah R; Harries AD; Manzi M; Gomani P; Teck R; Phillips M; Firmenich P
    PLoS One; 2006 Dec; 1(1):e121. PubMed ID: 17205125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The re-emergence of tuberculosis.
    Porter JD; McAdam KP
    Annu Rev Public Health; 1994; 15():303-23. PubMed ID: 8054087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral drug supply challenges in the era of scaling up ART in Malawi.
    Schouten EJ; Jahn A; Ben-Smith A; Makombe SD; Harries AD; Aboagye-Nyame F; Chimbwandira F
    J Int AIDS Soc; 2011 Jul; 14 Suppl 1(Suppl 1):S4. PubMed ID: 21967844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
    Dutta A; Barker C; Kallarakal A
    PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaling up antiretroviral therapy in Malawi-implications for managing other chronic diseases in resource-limited countries.
    Harries AD; Zachariah R; Jahn A; Schouten EJ; Kamoto K
    J Acquir Immune Defic Syndr; 2009 Nov; 52 Suppl 1():S14-6. PubMed ID: 19858929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi.
    Kumwenda M; Tom S; Chan AK; Mwinjiwa E; Sodhi S; Joshua M; van Lettow M
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1663-9. PubMed ID: 22118175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive spill-over effects of ART scale up on wider health systems development: evidence from Ethiopia and Malawi.
    Rasschaert F; Pirard M; Philips MP; Atun R; Wouters E; Assefa Y; Criel B; Schouten EJ; Van Damme W
    J Int AIDS Soc; 2011 Jul; 14 Suppl 1(Suppl 1):S3. PubMed ID: 21967809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: an example from Malawi.
    Harries AD; Schouten EJ; Makombe SD; Libamba E; Neufville HN; Some E; Kadewere G; Lungu D
    Bull World Health Organ; 2007 Feb; 85(2):152-5. PubMed ID: 17308737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.
    Tagar E; Sundaram M; Condliffe K; Matatiyo B; Chimbwandira F; Chilima B; Mwanamanga R; Moyo C; Chitah BM; Nyemazi JP; Assefa Y; Pillay Y; Mayer S; Shear L; Dain M; Hurley R; Kumar R; McCarthy T; Batra P; Gwinnell D; Diamond S; Over M
    PLoS One; 2014; 9(11):e108304. PubMed ID: 25389777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors impacting the provision of antiretroviral therapy to people living with HIV: the view from Haiti.
    Rouzier V; Farmer PE; Pape JW; Jerome JG; Van Onacker JD; Morose W; Joseph P; Leandre F; Severe P; Barry D; Deschamps MM; Koenig SP
    Antivir Ther; 2014; 19 Suppl 3():91-104. PubMed ID: 25310257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scaling-up antiretroviral therapy in Malawi.
    Jahn A; Harries AD; Schouten EJ; Libamba E; Ford N; Maher D; Chimbwandira F
    Bull World Health Organ; 2016 Oct; 94(10):772-776. PubMed ID: 27843168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building a durable response to HIV/AIDS: implications for health systems.
    Atun R; Bataringaya J
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S91-5. PubMed ID: 21857305
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.